SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 4.20 |
| Enterprise Value ($M) | 16.72 |
| Book Value ($M) | -12.59 |
| Book Value / Share | -8.21 |
| Price / Book | -0.33 |
| NCAV ($M) | -17.83 |
| NCAV / Share | -11.63 |
| Price / NCAV | -0.24 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -13.58 |
| Return on Assets (ROA) | -2.21 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.16 |
| Current Ratio | 0.16 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 3.30 |
| Assets | 8.54 |
| Liabilities | 21.13 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -23.77 |
| Net Income | -26.90 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -19.46 |
| Cash from Investing | -0.37 |
| Cash from Financing | 18.41 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | YA II PN, Ltd. | -100.00 | ||
| 13D | Ralston Shannon | 19.99 | ||
| 13D/A | Bersani Pietro | 8.75 | 52.91 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| KAYS – Kaya Holdings, Inc. | KBYPF – Kobayashi Pharmaceutical Co., Ltd. |
| KLDO – Kaleido Biosciences, Inc. | KYKOF – Kyowa Kirin Co., Ltd. |
| LABFF – Laboratorios Farmaceuticos Rovi, S.A. |
Financial data and stock pages provided by
Fintel.io